"What is of note, however, is the discrepancy we see in
statin treatment and adherence rates between genders."
— Sharon Jhawar, Pharm.D., chief pharmacy officer at SCAN Health
Plan, explaining to Radar on
Drug Benefits how her plan’s experience validated recent research
finding persistent gender bias when it comes to statin therapy.
No comments:
Post a Comment